Acorda Therapeutics, Inc. (ACOR) Social Stream
ACORDA THERAPEUTICS INC (ACOR) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering ACOR.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-06-17 | 1 | $10 | $10 | $10 | $15.09 | -33.73% |
| NA | 1 | $NA | $NA | $NA | $15.09 | NA% |
Price Target Last Issued NA NA, NA
The Trend in the Analyst Price Target
ACOR's average price target has moved up $6.33 over the prior 39 weeks.
500 - Internal server error
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|
ACOR Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1 | 1 | 0 | 0 | 0 | 0 | 1 |
The Trend in the Broker Recommendations
ACOR's average broker recommendation rating improved by 1 over the prior 153 days.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- To contextualize these metrics, consider that out of all US stocks, ACORDA THERAPEUTICS INC's number of analysts covering the stock is greater than just about none of of them.
- To contextualize these metrics, consider that out of all US stocks, ACORDA THERAPEUTICS INC's variance in analysts' estimates is lower than nearly 100% of them.
- ACOR has a higher upside potential (average analyst target price relative to current price) than 2.99% of stocks in the small market cap category.
- In the context of Healthcare stocks, ACORDA THERAPEUTICS INC's average analyst price target is higher than 17.21% of them.
In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to ACORDA THERAPEUTICS INC are ITOS, MTEX, and PROC.
View All Top Stocks by Price Target
Is ACOR a Buy, Hold or Sell? See the POWR Ratings now!